PEN.NYSEPenumbra INC

Form 4: Penumbra Inc. Executive Johanna Roberts Reports Stock Sales

Sentiment:

SEC Form 4 Filing


Johanna Roberts, EVP, Gen. Counsel & Secretary of Penumbra Inc., reports the sale of common stock on October 1, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

  • On October 1, 2024, Johanna Roberts, EVP, Gen. Counsel & Secretary of Penumbra Inc., sold shares of common stock.
  • The sales were executed in multiple transactions at varying prices, ranging from $187.32 to $194.44.
  • A total of 820 shares were sold.
  • These sales were conducted under a pre-existing Rule 10b5-1 trading plan.
  • Following the reported transactions, Roberts beneficially owns 60,488 shares of Penumbra Inc. common stock, a portion of which is subject to vesting.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock sales by an executive under a pre-arranged plan. It doesn't inherently convey positive or negative sentiment.

Positives

  • The sales were executed under a pre-arranged Rule 10b5-1 trading plan, which can mitigate concerns about insider trading.

Risks

  • Executive stock sales can sometimes be perceived negatively by investors, although the use of a 10b5-1 plan can alleviate these concerns.

Industry Context

Executive stock sales are a common occurrence in publicly traded companies and are often scrutinized by investors for insights into management's perspective on the company's future prospects. The use of a 10b5-1 trading plan is a standard practice to ensure compliance with insider trading regulations.

Comparison to Industry Standards

  • Executive stock sales are a common practice across the industry.
  • Companies like Medtronic, Stryker, and Boston Scientific also see regular Form 4 filings related to executive stock transactions.
  • The use of 10b5-1 trading plans is a widespread method for executives to manage their stock holdings while avoiding potential insider trading issues.

Stakeholder Impact

  • The stock sales may have a minor impact on shareholders, but the use of a 10b5-1 plan suggests the transactions were pre-planned and not based on any specific inside information.

Key Dates

DateDescription
10/01/2024Date of stock sale transactions
10/03/2024Date of Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.